Dr. Mike Dawson, Head of Biology
Oxford Drug Design, a pre-clinical stage therapeutics spinout from Oxford University, is discovering innovative anti-cancer therapeutics supported by pioneering compu...
Dr. Richard Cooper, Head of ML & Methods Development
Dr. Richard Cooper, Head of ML & Methods Development
Oxford Drug Design, a pre-clinical stage therapeutics spinout from Oxford University, is discovering innovative anti-cancer therapeutics supported...
Dr Paul Finn, CSO of Oxford Drug Design
Oxford Drug Design, a pre-clinical stage therapeutics spinout from Oxford University, is discovering innovative anti-cancer therapeutics supported by pioneeri...
Dr. Alan D. Roth, CEO of Oxford Drug Design
Oxford Drug Design, a pre-clinical stage therapeutics spinout from Oxford University, is discovering innovative anti-cancer therapeutics supported by pio...
